BioDiverse Cores







CreaGen’s BDC program has collections of novel natural product and natural product-like scaffolds. Many of these scaffolds are target relevant cores that are designed to produce small molecule IP. These low molecular weight compounds are ideal for fragment-based screening. These cores have been designed with multiple diversity points to facilitate rapid synthesis of analogs that will provide SAR information. The multiple diversity points can also be be utilized to improve the pharmacokinetic properties of the target molecules such as solubility, bioavailability, selectivity and potency. CreaGen currently has 100 scaffolds in its BDC collection and continues to add approximately 25 new scaffolds per quarter. Our partners will have immediate access to our collections on a non-exclusive basis to develop potential new starting points for research programs.


Fax, email or phone inquiries.


CreaGen Inc.,

299 Washington Street,
Woburn, MA 01801

Dr. Raj Rajur, Ph.D., Chairman & CEO

Voice +1 (781) 938-1122 ext. 112
Fax +1 (781) 938-1123
rrajur@creageninc.com

Ms . Anny Chum, Project manager & Director of operations & Administration

Voice (781) 938-1122 ext. 111
Fax (781) 938-1123
anny@creageninc.com



Subscribe


Sign up for CreaGen Inc newsletter to receive all the news.




Social networks



Twitter

#WeCare




Contact us




Send us an email

rrajur@creageninc.com



Subscribe


Sign up for Medicare newsletter to receive all the news offers and discounts from Medicare eye clinic.




Social networks



Twitter

#WeCare





© CreaGen Inc 2019. All rights reserved. Designed by Inqude



© CreaGen Inc 2019. All rights reserved. Designed by Inqude